Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab and Dexamethasone vs Ranibizumab for DME
NCT04601675Unknown
- Sponsor
- He Eye Hospital
- Start
- Oct 2020
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of dexamethasone in diabetic macular edema (DME), sponsored by He Eye Hospital. Primary endpoints: Mean change in monocular Best Corrected Visual Acuity at 6 months and Mean change in binocular Best Corrected Visual Acuity at 6 months. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT04601675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04601675.